Mechanistic basis of the role of Cbx3 in negatively regulating osteoclast differentiation through epigenetic modification
Cbx3通过表观遗传修饰负调节破骨细胞分化作用的机制基础
基本信息
- 批准号:10463857
- 负责人:
- 金额:$ 49.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-06 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressBindingBinding ProteinsBinding SitesBiologyBone DiseasesCCAAT-Enhancer-Binding Protein-alphaCathepsin CChIP-seqChromatinComplexCre lox recombination systemDataDevelopmentDiseaseEpigenetic ProcessExhibitsFOS geneFemaleFoundationsGene ExpressionGene Expression RegulationGene SilencingGenesGenetic TranscriptionGoalsHeterochromatinHomeostasisHomologous GeneImmunoprecipitationKnockout MiceMass Spectrum AnalysisMediatingMetabolic Bone DiseasesModelingModificationMolecularMusOsteoclastsOsteolyticOsteoporosisPathologicPatternPhenotypePhysiologicalProteinsRegulationRoleSignal TransductionSkeletal DevelopmentSkeletal boneTestingTransgenic Organismsbonebone losscathepsin Kconditional knockoutdesignepigenetic regulationgain of functiongenome-widehistone methylationinsightloss of functionmalemonocytemouse modelnew therapeutic targetnovel therapeutic interventionosteoclastogenesisoverexpressionpreventpromotertherapeutically effectivetranscription factortranscriptome sequencing
项目摘要
The long term goal of this study is to develop safer and effective therapeutic approach for bone loss caused by
excessive osteoclast (OC) differentiation implicated in many metabolic bone diseases. The immediate goal of
this application is to understand how OC differentiation is regulated through negative signaling mediated by
transcription factors and epigenetic regulators, which may serve as novel therapeutic targets for bone diseases
such as osteoporosis. Current therapies for osteolytic diseases are hindered by lack of understanding of the
mechanisms underlying the negative regulation of OC function to prevent bone loss. Moreover, the
mechanism(s) underlying how transcriptional factors and epigenetic factors co-regulate, especially negatively
co-regulate, OC differentiation and function remain unclear. We have identified Cbx3/HP1γ. Our subsequent
immunoprecipitation analysis confirmed that C/EBPα interacts with Cbx3/HP1γ in OCs. Notably, our preliminary
data showed that Cbx3/HP1γ overexpression inhibited OC differentiation and activity, while Cbx3/HP1γ silencing
enhanced OC lineage commitment and formation. Consistently, Cbx3/HP1γ-deficient mice were found to exhibit
osteoporosis-like phenotype due to enhanced OC formation and activity. Interestingly, through ChIP analysis, we
found several binding sites of Cbx3/HP1γ on the promoters of C/EBPα regulated OC genes, NFATC1 and
C-FOS. Our RNA-seq analysis also revealed that Cbx3 deficiency in monocytes led to increased OC gene
expression. Collectively, the preliminary data indicated that Cbx3 can restrict C/EBPα-mediated OC
differentiation and activity. Based on our preliminary studies, we hypothesize that Cbx3 negatively regulates
osteoclast differentiation through interacting with C/EBPα and epigenetic factors as a result of epigenetic
modification and preventing osteoclast gene expression in bone homeostasis. We will test the hypothesis
through three specific aims. In Aim 1, we examine the function of Cbx3 in OC differentiation, skeletal
development and bone homeostasis under physiological and pathological conditions through characterization of
the phenotypes and pathomechanism in two Cbx3 CKO mouse models through loss-of-function studies. In Aim
2, we determine the role of Cbx3 in OC differentiation, skeletal development and bone homeostasis under
physiological and pathological conditions by characterizing the phenotypes and pathomechanism in Cbx3
conditional transgenic overexpression mice through gain-of-function approach. We define the molecular
mechanism underlying how Cbx3 negatively regulates OC differentiation through interacting with C/EBPα and
controlling epigenetic modification in Aim 3. The study will elucidate the mechanism(s) through which Cbx3
cooperates with transcriptional factors and other epigenetic factors to negatively regulate OC differentiation and
activity. Insights gained from this study will not only address the basic scientific question about epigenetic
regulation of gene expression in OC biology, but also will provide the foundation for the ultimate goal of
facilitating the design of safer and novel therapeutic approach for osteolytic diseases (e.g. osteoporosis).
这项研究的长期目标是开发更安全有效的治疗方法来治疗由骨质疏松引起的骨质流失
破骨细胞(OC)过度分化与许多代谢性骨疾病有关。近期目标是
该应用旨在了解 OC 分化是如何通过负信号介导的进行调节的
转录因子和表观遗传调节因子,可能作为骨疾病的新治疗靶点
例如骨质疏松症。目前对溶骨性疾病的治疗因缺乏对溶骨性疾病的了解而受到阻碍。
OC 功能负调控防止骨丢失的潜在机制。此外,
转录因子和表观遗传因子如何共同调节(尤其是负面调节)的机制
共同调节,OC 分化和功能仍不清楚。我们已经鉴定出 Cbx3/HP1γ。我们后续的
免疫沉淀分析证实,OC 中 C/EBPα 与 Cbx3/HP1γ 相互作用。值得注意的是,我们初步
数据显示,Cbx3/HP1γ过表达抑制OC分化和活性,而Cbx3/HP1γ沉默
增强 OC 血统承诺和形成。一致地,Cbx3/HP1γ 缺陷小鼠被发现表现出
由于 OC 形成和活性增强而导致骨质疏松症样表型。有趣的是,通过 ChIP 分析,我们
在 C/EBPα 调节的 OC 基因 NFATC1 和 NFATC1 的启动子上发现了 Cbx3/HP1γ 的几个结合位点
C-FOS。我们的 RNA-seq 分析还表明,单核细胞中的 Cbx3 缺陷导致 OC 基因增加
表达。总的来说,初步数据表明 Cbx3 可以限制 C/EBPα 介导的 OC
分化和活性。根据我们的初步研究,我们假设 Cbx3 负向调节
破骨细胞通过与 C/EBPα 和表观遗传因子相互作用而分化
修饰和防止骨稳态中破骨细胞基因表达。我们将检验假设
通过三个具体目标。在目标 1 中,我们检查了 Cbx3 在 OC 分化、骨骼
通过表征生理和病理条件下的发育和骨稳态
通过功能丧失研究研究两种 Cbx3 CKO 小鼠模型的表型和病理机制。瞄准
2、我们确定了Cbx3在OC分化、骨骼发育和骨稳态中的作用
通过表征 Cbx3 的表型和病理机制来了解生理和病理条件
通过功能获得方法有条件转基因过度表达小鼠。我们定义分子
Cbx3 通过与 C/EBPα 相互作用负向调节 OC 分化的机制
控制目标 3 中的表观遗传修饰。该研究将阐明 Cbx3 的机制
与转录因子和其他表观遗传因子合作负向调节 OC 分化和
活动。从这项研究中获得的见解不仅将解决有关表观遗传的基本科学问题
OC生物学中基因表达的调控,也将为最终目标提供基础
促进针对溶骨性疾病(例如骨质疏松症)设计更安全、新颖的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YI-PING LI其他文献
YI-PING LI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YI-PING LI', 18)}}的其他基金
G13 signaling attenuates periodontal inflammation and alveolar bone loss in the mouse model of age-associated periodontitis
G13 信号传导可减轻年龄相关性牙周炎小鼠模型中的牙周炎症和牙槽骨丢失
- 批准号:
10404267 - 财政年份:2021
- 资助金额:
$ 49.59万 - 项目类别:
Inhibiting inflammation and bone erosion in periodontal disease by targeting cell endogenous negative signaling
通过靶向细胞内源性负信号传导抑制牙周病中的炎症和骨侵蚀
- 批准号:
10405318 - 财政年份:2021
- 资助金额:
$ 49.59万 - 项目类别:
Mechanism of chemotherapy potentiation of muscle wasting in cancer cachexia
化疗增强癌症恶病质肌肉萎缩的机制
- 批准号:
10362568 - 财政年份:2021
- 资助金额:
$ 49.59万 - 项目类别:
G13 signaling attenuates periodontal inflammation and alveolar bone loss in the mouse model of age-associated periodontitis
G13 信号传导可减轻年龄相关性牙周炎小鼠模型中的牙周炎症和牙槽骨丢失
- 批准号:
10444932 - 财政年份:2021
- 资助金额:
$ 49.59万 - 项目类别:
Inhibiting inflammation and bone erosion in periodontal disease by targeting cell endogenous negative signaling
通过靶向细胞内源性负信号传导抑制牙周病中的炎症和骨侵蚀
- 批准号:
10327686 - 财政年份:2021
- 资助金额:
$ 49.59万 - 项目类别:
Inhibiting inflammation and bone erosion in periodontal disease by targeting cell endogenous negative signaling
通过靶向细胞内源性负信号传导抑制牙周病中的炎症和骨侵蚀
- 批准号:
10559645 - 财政年份:2021
- 资助金额:
$ 49.59万 - 项目类别:
Mechanism of chemotherapy potentiation of muscle wasting in cancer cachexia
化疗增强癌症恶病质肌肉萎缩的机制
- 批准号:
10550259 - 财政年份:2021
- 资助金额:
$ 49.59万 - 项目类别:
Targeting circulating HSP70 and HSP90 for the treatment of cancer cachexia
靶向循环 HSP70 和 HSP90 治疗癌症恶病质
- 批准号:
10212970 - 财政年份:2020
- 资助金额:
$ 49.59万 - 项目类别:
Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in rheumatoid arthritis
表征树突状细胞和巨噬细胞中的负信号传导以减轻类风湿性关节炎的炎症和骨质破坏
- 批准号:
10616608 - 财政年份:2020
- 资助金额:
$ 49.59万 - 项目类别:
Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in rheumatoid arthritis
表征树突状细胞和巨噬细胞中的负信号传导以减轻类风湿性关节炎的炎症和骨质破坏
- 批准号:
10405848 - 财政年份:2020
- 资助金额:
$ 49.59万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 49.59万 - 项目类别:
Discovery Projects
Structural classification of NHEJ pathways; unravelling the role of Ku-binding proteins
NHEJ通路的结构分类;
- 批准号:
MR/X00029X/1 - 财政年份:2023
- 资助金额:
$ 49.59万 - 项目类别:
Research Grant
BRC-BIO: Evolutionary Patterns of Ice-Binding Proteins in North Pacific Intertidal Invertebrates
BRC-BIO:北太平洋潮间带无脊椎动物冰结合蛋白的进化模式
- 批准号:
2312378 - 财政年份:2023
- 资助金额:
$ 49.59万 - 项目类别:
Standard Grant
Exploring the roles and functions of sex steroid hormone receptor-associated RNA binding proteins in the development of geriatric diseases.
探索性类固醇激素受体相关 RNA 结合蛋白在老年疾病发展中的作用和功能。
- 批准号:
23K06408 - 财政年份:2023
- 资助金额:
$ 49.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
UV Plasmon-Enhanced Chiroptical Spectroscopy of Membrane-Binding Proteins
膜结合蛋白的紫外等离子增强手性光谱
- 批准号:
10680969 - 财政年份:2023
- 资助金额:
$ 49.59万 - 项目类别:
Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins
研究帕金森病蛋白 α-突触核蛋白和 RNA 结合蛋白之间的生理和病理生理联系
- 批准号:
10744556 - 财政年份:2023
- 资助金额:
$ 49.59万 - 项目类别:
Structural and computational analysis of immune-related RNA-binding proteins
免疫相关 RNA 结合蛋白的结构和计算分析
- 批准号:
23K06597 - 财政年份:2023
- 资助金额:
$ 49.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of carbohydrate-binding proteins and their applications
碳水化合物结合蛋白的表征及其应用
- 批准号:
23K05034 - 财政年份:2023
- 资助金额:
$ 49.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A machine learning approach to identify carbon dioxide-binding proteins for sustainability and health
一种机器学习方法来识别二氧化碳结合蛋白以实现可持续发展和健康
- 批准号:
2838427 - 财政年份:2023
- 资助金额:
$ 49.59万 - 项目类别:
Studentship
The role of RNA binding proteins in heart development and congenital heart defects
RNA结合蛋白在心脏发育和先天性心脏缺陷中的作用
- 批准号:
10827567 - 财政年份:2023
- 资助金额:
$ 49.59万 - 项目类别: